These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12605877)
1. Neurodegenerative disorders of protein aggregation. Shastry BS Neurochem Int; 2003 Jul; 43(1):1-7. PubMed ID: 12605877 [TBL] [Abstract][Full Text] [Related]
2. Corruption and spread of pathogenic proteins in neurodegenerative diseases. Walker LC; LeVine H J Biol Chem; 2012 Sep; 287(40):33109-15. PubMed ID: 22879600 [TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases. Boyd RJ; Avramopoulos D; Jantzie LL; McCallion AS J Neuroinflammation; 2022 Sep; 19(1):223. PubMed ID: 36076238 [TBL] [Abstract][Full Text] [Related]
4. Protein aggregation and neurodegenerative disease. Ross CA; Poirier MA Nat Med; 2004 Jul; 10 Suppl():S10-7. PubMed ID: 15272267 [TBL] [Abstract][Full Text] [Related]
5. Few-shot prediction of amyloid β accumulation from mainly unpaired data on biomarker candidates. Yada Y; Naoki H NPJ Syst Biol Appl; 2023 Nov; 9(1):59. PubMed ID: 37993458 [TBL] [Abstract][Full Text] [Related]
6. Chemical Modification of the Amino Groups of Human Insulin: Investigating Structural Properties and Amorphous Aggregation of Acetylated Species. Kamelnia R; Goliaei B; Peyman Shariatpanahi S; Mehrnejad F; Ghasemi A; Zare Karizak A; Ebrahim-Habibi A Protein J; 2023 Aug; 42(4):383-398. PubMed ID: 37395911 [TBL] [Abstract][Full Text] [Related]
7. Tubulin Cytoskeleton in Neurodegenerative Diseases-not Only Primary Tubulinopathies. Cyske Z; Gaffke L; Pierzynowska K; Węgrzyn G Cell Mol Neurobiol; 2023 Jul; 43(5):1867-1884. PubMed ID: 36352320 [TBL] [Abstract][Full Text] [Related]
8. Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases. Ulloa-Aguirre A; Zariñán T; Gutiérrez-Sagal R; Tao YX Front Endocrinol (Lausanne); 2022; 13():934685. PubMed ID: 36093106 [TBL] [Abstract][Full Text] [Related]
9. At the Intersection of Natural Structural Coloration and Bioengineering. Chatterjee A Biomimetics (Basel); 2022 May; 7(2):. PubMed ID: 35645193 [TBL] [Abstract][Full Text] [Related]
10. Unravelling the Novel Effects of Three Volatile Compounds in Preventing Fibril Formation of Disease Related Tau and α-Synuclein Proteins- Towards Identifying Candidate Aromatic Substances for Treating Neurodegenerative Diseases. Moeini Z; Seraj Z; Zohoorian Abootorabi T; Ashrafi-Kooshk M; Riazi G; Saboury AA; Seyedarabi A Front Pharmacol; 2022; 13():793727. PubMed ID: 35392564 [No Abstract] [Full Text] [Related]
11. Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects. Ulloa-Aguirre A; Zariñán T; Jardón-Valadez E Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830210 [TBL] [Abstract][Full Text] [Related]